KaliVir Immunotherapeutics

KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment.

Add To Watchlist
General Information
Company Name
KaliVir Immunotherapeutics
Founded Year
2019
Location (Offices)
Pittsburgh, United States +1
Founders / Decision Makers
Helena Chaye - Chief Executive Officer Kaia Sipple, - Controller
Number of Employees
43
Industries
Health Care, Health and Wellness, Pharmaceutical
Funding Stage
Series A
Social Media

KaliVir Immunotherapeutics - Company Profile

KaliVir Immunotherapeutics is a pioneering company in the health care and pharmaceutical industries, aiming to revolutionize cancer treatment. Established in 2019, the company focuses on oncolytic viral immunotherapy, leveraging a virus' natural ability to eliminate cancer cells. This cutting-edge approach combines proprietary technologies with licensed advancements from the University of Pittsburgh's renowned research programs. Notably, KaliVir secured a significant Series A investment on March 16, 2022, attracting support from Company K Partners, Premier Partners, K Partners, and QUAD Investment Management. Headquartered in the United States, KaliVir Immunotherapeutics exemplifies innovation and potential in the vital field of cancer treatment.

Taxonomy: Immunotherapy, Cancer treatment, Oncolytic viral therapy, Cancer cell targeting, Virotherapy, Oncolytic virus research, University collaboration, Tumor targeting, Next-generation therapy

Funding Rounds & Investors of KaliVir Immunotherapeutics (1)

View All
Funding Stage Amount No. Investors Investors Date
Series A Unknown 4
Company K Partners, investor in KaliVir Immunotherapeutics's Series A round Premier Partners, investor in KaliVir Immunotherapeutics's Series A round K Partners, investor in KaliVir Immunotherapeutics's Series A round QUAD Investment Management, investor in KaliVir Immunotherapeutics's Series A round
16 Mar 2022

Latest News of KaliVir Immunotherapeutics

View All

No recent news or press coverage available for KaliVir Immunotherapeutics.

Similar Companies to KaliVir Immunotherapeutics

View All
ViraTherapeutics GmbH - Similar company to KaliVir Immunotherapeutics
ViraTherapeutics GmbH We make cancer immunotherapies more powerful.
Seneca Therapeutics, Inc. - Similar company to KaliVir Immunotherapeutics
Seneca Therapeutics, Inc. Seneca Therapeutics is developing a novel cancer therapy (oncolytic immunotherapeutic) for patients with solid cancers
VacV Biotherapeutics - Similar company to KaliVir Immunotherapeutics
VacV Biotherapeutics Developing oncolytic viruses as therapeutics for cancer
GeneMedicine - Similar company to KaliVir Immunotherapeutics
GeneMedicine Biopharmaceutical company focusing on R&D and commercializing its oncolytic adenovirus platform for cancer treatment.
IconOVir Bio - Similar company to KaliVir Immunotherapeutics
IconOVir Bio Pushing the envelope: Our mission is to cure cancer and restore life to every patient everywhere
Circle Decoration Circle Decoration

Want to dive deeper into KaliVir Immunotherapeutics? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now